Key statistics
On Friday, Dr Reddy's Laboratories Ltd (RDDA:FRA) closed at 71.00, -6.58% below its 52-week high of 76.00, set on Aug 12, 2024.
52-week range
Open | 71.00 |
---|---|
High | 71.00 |
Low | 71.00 |
Bid | 70.50 |
Offer | 72.00 |
Previous close | 71.00 |
Average volume | 19.80 |
---|---|
Shares outstanding | 166.59m |
Free float | 166.00m |
P/E (TTM) | 19.73 |
Market cap | 13.16bn USD |
EPS (TTM) | 3.97 USD |
Annual div (ADY) | 0.4403 EUR |
---|---|
Annual div yield (ADY) | 0.62% |
Div ex-date | Jul 30 2024 |
Div pay-date | Aug 12 2024 |
Data delayed at least 15 minutes, as of Oct 04 2024 07:17 BST.
More ▼
Press releases
- Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
- Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
- Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar
- Dr. Reddy’s Q1FY25 Financial Results